Roundtables - Workshops - Conferences

Workshop: Overview of the Research Oriented Market Access (ROMA) framework for Value of Information (VOI) Analysis

Tuesday, February 13, 2024
Time: 5:30 p.m. – 8:30 p.m. MST

Health technology assessment (HTA) uses evidence appraisal and synthesis with economic evaluation to inform adoption decisions. Standard HTA processes sometimes struggle to:

  • Support decisions which involve significant uncertainty, and
  • Encourage continued generation of and adaptation to new evidence.

The Research Oriented Market Access (ROMA) framework addresses these challenges by providing tools to decision makers that integrate into existing HTA methods.

Under ROMA, HTA processes align to life-cycle management. It introduces Value of Information analysis (VOI) into HTA methods in a manner that optimizes decision uncertainty while minimizing – and even saving – additional analytic time. Where decision uncertainty exists, we recommend risk-based pricing and research-oriented managed access. ROMA enables the adoption of high-value high-risk innovations in time-limited decision settings, whilst improving health system sustainability through risk-sharing and reducing uncertainty.

Contractual procurement agreements define the terms of re-assessment and provide additional decision options to HTA agencies. ROMA extends current VOI methods to inform agreements, leveraging routine, administrative data as well as registries to reduce uncertainty. Responsiveness to evolving evidence is improved through contractually embedded decision rules to simplify reassessment. ROMA allows conditional adoption to obtain additional information, with confidence that the net value of that adoption decision is positive.

In this workshop, we explain the principles of ROMA and provide hands-on guidance on its implementation within existing decision-making processes. This workshop will:

  • Explain the ROMA framework and how it can address three challenges faced under standard HTA: (i) health system sustainability, (ii) evolving evidence, and (iii) uncertainty.
  • Demonstrate how ROMA is built around on-market evidence generation and risk-based pricing strategies. Where decision uncertainty exists, we will illustrate how risk-based pricing and research-oriented managed access can improve the value proposition for payers.
  • Explain how contractual procurement agreements can be used to define the terms of re-assessment and provide additional decision options to HTA agencies.

Format:
3-hour online workshop with Q&A